menu
    • menu

    Company profile for Accro Bioscience

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At the end of 2017, a group of industrial veterans and scientists with decades of experience in drug research and development established Accro Bioscience (Suzhou) Limited. Wholly owned by Accro Bioscience (HK) Limited, Accro Bioscience (Suzhou) Limited is a clinical-stage biotech company with a core focus on molecular mechanisms of regulated cell death and related pathogenesis in human diseases. Through harnessing the power o...
    At the end of 2017, a group of industrial veterans and scientists with decades of experience in drug research and development established Accro Bioscience (Suzhou) Limited. Wholly owned by Accro Bioscience (HK) Limited, Accro Bioscience (Suzhou) Limited is a clinical-stage biotech company with a core focus on molecular mechanisms of regulated cell death and related pathogenesis in human diseases. Through harnessing the power of science and drug discovery, the Company has developed a robust portfolio with innovative compounds in various stages spanning from lead optimization to clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Accro BioscienceChina Flag
    Country
    Country
    China
    Address
    Address
    Unit E37, North Building A1, BioBay, No.218 Xinghu Street, Suzhou Industrial P...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.accro.com.cn/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Accro Grant Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor
    Accro Grant Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor

    29 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/accro-bioscience-grants-fosun-pharma-exclusive-rights-for-tyk2-jak1-inhibitor-in-greater-china/

    CONTRACTPHARMA
    29 Aug 2025
    Share Share
    Accropeutics Reports Positive Phase 2 Data for AC-201 in Psoriasis
    Accropeutics Reports Positive Phase 2 Data for AC-201 in Psoriasis

    20 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/accropeutics-announces-positive-data-from-phase-2-trial-of-ac-201-an-oral-selective-tyk2jak1-inhibitor-for-the-treatment-of-moderate-to-severe-plaque-psoriasis-302461241.html

    PR NEWSWIRE
    20 May 2025
    Share Share
    Blueprint Medicines Reports Q4 and Full Year 2024 Results
    Blueprint Medicines Reports Q4 and Full Year 2024 Results

    13 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blueprint-medicines-reports-fourth-quarter-and-full-year-2024-results-302375527.html

    PR NEWSWIRE
    13 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search